Fibromyalgia in human immunodeficiency virus infection. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Fibromyalgia in human immunodeficiency virus infection.

J Rheumatol. 1990 Sep;17(9):1202-6. Unique Identifier : AIDSLINE MED/91148062
Buskila D; Gladman DD; Langevitz P; Urowitz S; Smythe HA; University of Toronto Rheumatic Disease Unit, Wellesley Hospital,; ON, Canada.

Abstract: Tenderness was assessed by point count and by scored palpation in 51 patients with human immunodeficiency virus (HIV) infection as well as 51 patients with rheumatoid arthritis (RA) and 50 patients with psoriatic arthritis (PsA). Fifteen of 51 (29%) patients with HIV infection met criteria for fibromyalgia, based on the presence of 10 tender (of 14) fibrositic points. Similar results were observed among patients with PsA (24%). The prevalence of fibromyalgia was higher among patients with RA (57%). Patients with HIV and PsA were less tender than patients with RA. Fibromyalgia in patients with HIV was significantly associated with myalgia and arthralgia, but not with age, duration of HIV infection, stage of HIV disease, or zidovudine therapy.
Keywords: Adult Arthritis, Psoriatic/COMPLICATIONS/EPIDEMIOLOGY/PATHOLOGY Arthritis, Rheumatoid/COMPLICATIONS/EPIDEMIOLOGY/PATHOLOGY Female Fibromyalgia/*COMPLICATIONS/EPIDEMIOLOGY/PATHOLOGY Human HIV Infections/*COMPLICATIONS/EPIDEMIOLOGY/PATHOLOGY Male Middle Age Opportunistic Infections/*COMPLICATIONS/EPIDEMIOLOGY/PATHOLOGY Prevalence JOURNAL ARTICLEKWDadultarthritis,psoriatic/complications/epidemiology/pathologyarthritis,rheumatoid/complications/epidemiology/pathologyfemalefibromyalgia/KWDcomplications/epidemiology/pathologyhumanhivinfections/KWDcomplications/epidemiology/pathologymalemiddleageopportunisticinfections/KWDcomplications/epidemiology/pathologyprevalencejournalarticle
910630
M9160674

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .